Cognitive Function

36

Review clinical trials related to Cognitive Function. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Function at Varying Dosages in Healthy Younger Adults With Self-reported Attention Problems

The goal of this clinical trial is to investigate the safety and efficacy of AP-Brain on cognitive function at varying dosages in healthy younger adults with self-reported attention problems. The main question it aims to answer is what Change from baseline to Day 56 between AP-Brain (1g, 3g, or 5g) and placebo in cognitive function, as assessed by the CNS VS Neurocognitive Index (NCI) score and complex attention. Participants will be asked to consume AP-Brain at 1 g, 3 g, or 5g, or Placebo and asked to complete memory assessment questionnaires.

Participants needed: 120
Trial details
Age: 18-39Biological sex: AllType: InterventionalSponsor: Rousselot BVBAUpdated: Jun 24, 2026Locations: 2
Eligibility criteria

Males and females 18-39 years of age, inclusive [+16]

Individuals who are pregnant, breast feeding, or planning to become pregnant dur... [+31]

Status: Not yet recruiting

Radicle Energy VBMTM: A Study Assessing the Impact of Health and Wellness Products on Fatigue and Related Health Outcomes

Radicle Energy VBMTM: A randomized, double-blind, placebo- controlled direct-to-consumer study assessing the impact of health and wellness products on fatigue and related health outcomes.

Participants needed: 550
Trial details
Age: 21-105Biological sex: AllType: InterventionalSponsor: Radicle ScienceUpdated: Jun 17, 2026Locations: 1
Eligibility criteria

Adults, at least 21 years of age at the time of electronic consent, inclusive of... [+17]

Status: Recruiting

Exploring Virtual Reality Adventure Training Exergaming

The current project aims to design and implement an 8-week Virtual Reality Adventure Therapy Exergaming (V-RATE) intervention focused on women veterans. A randomized controlled trial using a repeated measure design with a 1-month follow-up assessment will be employed to examine effects on physical and mental health outcomes.

Participants needed: 40
Trial details
Age: 18-45Biological sex: FemaleType: InterventionalSponsor: The University of Texas at ArlingtonUpdated: Jun 1, 2026Locations: 1
Eligibility criteria

Are between the ages of 18 and 45 [+1]

Unable to walk independently (e.g., use of any mobility assistive device such as... [+6]

Status: Recruiting

Effect of Hot Spring Therapy on Cognitive Function Recovery During Altitude Training

This randomized controlled trial aims to investigate the effects of hot spring bath therapy on cognitive function recovery, cerebral hemodynamics, and athletic performance in athletes undergoing altitude training. Participants will be randomly assigned to either a hot spring intervention group, a hot water control group, or a blank control group. The hot spring intervention group receives hot spring baths (38°C, 20 minutes) combined with altitude training; the hot water control group receives hot water baths (38°C, 20 minutes) combined with altitude training; and the blank control group receives standard recovery procedures combined with altitude training. Primary outcome measures include cognitive performance assessments (Stroop test, psychomotor vigilance test) and cerebral hemodynamic indicators (functional near-infrared spectroscopy, transcranial Doppler ultrasound). Secondary outcomes included exercise capacity (maximal oxygen uptake, triathlon performance, 500-meter test), blood lactate, and hematological parameters (white blood cells, neutrophils, platelets). These findings may provide evidence for non-pharmacological interventions to enhance cognitive recovery and brain adaptation during altitude training.

Participants needed: 27
Trial details
Age: 11-17Biological sex: AllType: InterventionalSponsor: Macao Polytechnic UniversityUpdated: May 27, 2026Locations: 1
Eligibility criteria

Male or female aged 11-17 years- Regular endurance training (≥3 sessions/week) f... [+5]

History of cardiovascular, respiratory, renal, or endocrine disorders [+5]

Status: Not yet recruiting

Mobile Dual-Task Brain and Balance Intervention for Concussion Recovery

This research study examines recovery after a sports-related concussion or mild head injury. Many athletes experience lingering problems with thinking, balance, and mood months after a concussion. We are testing a new home-based program called BraW-Day™ (Brain \& Walk Exercise Every Day). This 14-day program uses a mobile app on your smartphone and combines simple brain exercises (like counting backwards) with walking exercises. The idea is that doing these tasks together may help your brain and body recover more effectively. What You'll Do: * Two in-person visits at UNLV (baseline and after 14 days) for assessments * Daily 15-minute exercises at home using the BraW-Day app * Provide a small saliva sample for biomarker testing * Complete brief questionnaires about your symptoms and health Potential Benefits: You may experience improvements in thinking, balance, or mood. Even if you don't benefit directly, your participation will help researchers understand how to better support athletes recovering from concussion. Who Can Join: * Ages 18-40 * Had a sports-related concussion or mild head injury within the past 3-12 months * Have a smartphone and can safely do light walking and simple tasks This study is registered at ClinicalTrials.gov and approved by the UNLV Institutional Review Board to protect your safety and rights.

Participants needed: 20
Trial details
Age: 18-40Biological sex: AllType: InterventionalSponsor: Hyunhwa LeeUpdated: May 20, 2026Locations: 1
Eligibility criteria

Adults aged 18 to 40 years [+6]

Age younger than 18 years or older than 40 years [+7]

Status: Recruiting

Gait and Cognitive Function in Relation to Foot Arch Structure in Older Adults

This study aims to investigate the relationship between foot arch structure and spatiotemporal gait parameters and cognitive function in older adults. Foot arch integrity will be assessed using the Navicular Drop Test, and gait performance will be evaluated using the 10-Meter Walk Test. Cognitive-motor interaction will be examined through lower extremity reaction time using a light-based system. The study is designed as an observational cross-sectional analysis.

Participants needed: 50
Trial details
Age: 65+Biological sex: AllType: ObservationalSponsor: Balikesir UniversityUpdated: May 12, 2026Locations: 1
Eligibility criteria

Aged 65 years or older [+3]

Diagnosed neurological disorders affecting gait and motor control (e.g., stroke,... [+4]

Status: Not yet recruiting

Long-term Follow-up of Dexmedetomidine-esketamine and tDCS for Neurocognitive Complications After Surgery

Neurocognitive complications, mainly delirium and neurocognitive disorders, are common cerebral complications in older patients after surgery and associated with worse long-term outcomes. An ongoing 2×2 factorial trial conducted by the investigators plan to test the effects of perioperative dexmedetomidine-esketamine combination and transcranial direct current stimulation (tDCS) on postoperative neurocognitive complications in older patients. This long-term follow-up of the ongoing trial aims to investigate the effects of perioperative dexmedetomidine-esketamine combination and tDCS on long-term outcomes in older patients after noncardiac surgery.

Participants needed: 1,160
Trial details
Phase: Phase 4Age: 65-90Biological sex: AllType: InterventionalSponsor: Peking University First HospitalUpdated: May 12, 2026Locations: 6
Eligibility criteria

Aged 65 to 90 years; [+3]

Preoperative inability to communicate due to coma, severe dementia, endstage dis... [+8]

Status: Recruiting

Brain Health in Breast Cancer Survivors

Endocrine therapy (ET) is widely used to treat hormone receptor positive breast cancer and prevent recurrence by downregulating estrogen function. However, ETs readily cross the blood brain barrier and interfere with the action of estrogen in the brain. Estrogen supports cognition and menopausal status is closely linked to cognitive health in women. This has raised concern that anti-estrogen ETs may affect cognition and brain health in breast cancer survivors. However, evidence across existing studies is inconsistent and these effects remain poorly understood. The incomplete understanding of the effects of ET are likely due to limitations of earlier studies - namely, the under-appreciation of the role of menopausal status and insensitivity of standard cognitive measures. This research project will address these earlier limitations by specifically comparing ET effects by menopausal status, and using highly sensitive, task-related functional magnetic resonance imaging (fMRI) measures to assess the effects of ET on brain function.

Participants needed: 120
Trial details
Age: 35-65Biological sex: FemaleType: ObservationalSponsor: Jonsson Comprehensive Cancer CenterUpdated: May 11, 2026Locations: 1
Eligibility criteria

Age 35-65 [+2]

History of major or mild neurocognitive disorder or dementia [+12]

Status: Recruiting

Radicle Revive™: A Study Assessing the Impact of Health and Wellness Products on Menopausal-Related Health Issues Associated Health Outcomes and Related Health Outcomes

Radicle Revive™: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on menopausal-related health issues associated health outcomes.

Participants needed: 990
Trial details
Age: 40-105Biological sex: FemaleType: InterventionalSponsor: Radicle ScienceUpdated: Apr 23, 2026Locations: 1
Eligibility criteria

Adults, at least 40 years of age at the time of electronic consent, inclusive of... [+19]

Status: Recruiting

Radicle Clarity DSTTM: A Study Assessing the Impact of Health and Wellness Products on Mental Clarity and Related Health Outcomes

Radicle Clarity DSTTM: A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on mental clarity and related health outcomes.

Participants needed: 990
Trial details
Age: 35-60Biological sex: AllType: InterventionalSponsor: Radicle ScienceUpdated: Apr 21, 2026Locations: 1
Eligibility criteria

Adults, 35-60 years of age (inclusive) at the time of electronic consent, inclus... [+18]

Status: Recruiting

Brain Stimulation Effects on Cognitive Task Performance

The purpose of this study is to determine optimal task design parameters for the measurement of transcranial magnetic stimulation (TMS) effects on cognition.

Participants needed: 100
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Colorado State UniversityUpdated: Apr 8, 2026Locations: 1
Eligibility criteria

Right-handed [+1]

History of seizures or epilepsy [+21]

Status: Recruiting

IMST for Dementia Risk Reduction

Using a 2-arm, RCT approach, the primary goal of the study is to evaluate the feasibility and preliminary efficacy of Inspiratory Muscle Strength Training (IMST) as a non-pharmacologic intervention to reduce cardiovascular and cognitive risks in older adults. Next, investigators will examine secondary effects of IMST on mood, sleep quality, systemic inflammation, and physical/motor function. Finally, investigators will assess participant adherence and acceptability ratings of using an 8-week home-based IMST protocol in a diverse older adult sample.

Participants needed: 30
Trial details
Age: 60-80Biological sex: AllType: InterventionalSponsor: Florida State UniversityUpdated: Mar 27, 2026Locations: 1
Eligibility criteria

Ages 60-80 [+5]

tMoCA <18, or diagnosis of neurodegenerative illness at the discretion of princi... [+8]

Status: Recruiting

A Clinical Trial to Assess the Efficacy of a Single-dose of AlphaWave® L-Theanine on Cognitive Function in Healthy Adults With Moderate Stress

The goal of this clinical trial is to to assess the efficacy AlphaWave® L-Theanine on mental acuity/cognitive function and stress relief in healthy adults with moderate stress. The main question it aims to answer is: Is there a difference in change in mental acuity from pre- to post-dose between AlphaWave® L-Theanine and placebo? Participants will asked to provided a single dose of one capsule of a single dose of one capsule of AlphaWave® L-Theanine or one placebo capsule with 250 ml of room temperature water, and asked to complete tasks to assess cognitive function.

Participants needed: 40
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: Ethical Naturals, Inc.Updated: Mar 12, 2026Locations: 1
Eligibility criteria

Males and females 18 to 60 years of age, inclusive [+16]

Individuals who are pregnant, breast feeding, or planning to become pregnant dur... [+23]

Status: Recruiting

Investigation of Motor Imagery Ability, Body Awareness and Cognitive Functions in Type 2 Diabetes Mellitus

The aim of this study is to examine the relationship between motor imagery skills, body awareness and cognitive functions in individuals with Type 2 Diabetes mellitus.

Participants needed: 100
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Kutahya Health Sciences UniversityUpdated: Mar 10, 2026Locations: 1
Eligibility criteria

Being a type 2 DM patient between the ages of 18-65 for at least 5 years, [+2]

Having previous experience with Motor Imagery techniques or training, [+3]

Status: Not yet recruiting

Radicle Clarity CNM™: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes Among E-Gamers

Radicle Clarity CNM™: A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on cognitive function and related health outcomes among E-Gamers.

Participants needed: 600
Trial details
Age: 21-45Biological sex: AllType: InterventionalSponsor: Radicle ScienceUpdated: Feb 4, 2026Locations: 1
Eligibility criteria

Adults, aged 21 - 45 years at the time of electronic consent, inclusive of all e... [+15]

Status: Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the organs and tissue of the human body during x-ray, CT-scan or MRI investigations, doctors are using contrast media (a kind of dye) which can be given to patients by injection into a blood vessel or by mouth. In this study researchers want to find out whether so called gadolinium-based contrast agents (GBCAs) have an effect on body movement and mental skills when given to participants multiple times within 5 years. The study plans to enroll about 2076 participants suffering from a condition for which they are likely to have at least annually a MRI or another imaging examinations. Only adults up to 65 years will be considered to join this study. During the study duration of 5 years participants will receive annually a MRI or other imaging tests (such as CT-scan, x-ray) and will visit the study doctor at least 7 times for physical examinations, laboratory investigations and tests on body movement and mental skills.

Participants needed: 2,076
Trial details
Phase: Phase 4Age: 18-64Biological sex: AllType: InterventionalSponsor: GuerbetUpdated: Jan 22, 2026Locations: 51
Eligibility criteria

Participant must be neurologically normal, defined as free of unstable neurologi... [+6]

As evidenced by history or determined in the neurologic exam at screening, concu... [+11]

Status: Not yet recruiting

Oral Nutritional Supplementation in Children With Growth Concerns

Multi-center, single-blinded, randomized, controlled study consisting of two arms, to investigate the impact of an oral nutritional supplement in combination with dietary counseling on growth in children with growth concerns as compared to children who receive dietary counselling alone

Participants needed: 216
Trial details
Age: 24-41Biological sex: AllType: InterventionalSponsor: Société des Produits Nestlé (SPN)Updated: Dec 31, 2025
Eligibility criteria

Child's parent(s) is of legal age of majority (18 years of age), must understand... [+7]

Child is currently breastfed or is consuming breast milk. [+13]

Status: Recruiting

B-vitamins and Omega-3 Fatty Acids and Biomarkers of Brain Atrophy.

A poor nutrition status is a modifiable risk factor for cognitive decline and dementia. In particular, evidence links low status of certain B-vitamins and ω-3 fatty acids (ω-3 FA) with a greater risk of cognitive decline and dementia. Although these dietary components are typically investigated separately, post-hoc analyses of existing clinical trial data and experimental work indicate that B-vitamins and ω-3 FA may exert synergistic beneficial effects on processes related to brain health and cognition. However, this combination has not been tested directly in humans. In the proposed BOOMERANG project, we will study the effects of jointly supplementing with B-vitamins and a highly bioavailable ω-3 FA supplement, Lysoveta, on a robust biomarker of brain atrophy, the neurofilament light chain, in a double-blinded randomized controlled trial (RCT) over 3 months in older adults. We will also examine the secondary effects of the supplement of quality of life and cognitive function.

Participants needed: 96
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: University of OsloUpdated: Dec 31, 2025Locations: 1
Eligibility criteria

Age > 65 years [+2]

Unable to give informed consent [+9]

Status: Recruiting

Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators

The purpose of this study is to evaluate the dose-dependent effects of glucosyl-hesperidin (CITRAPEAK) supplementation on exercise performance, recovery indicators, blood flow, cognitive function, mood, sleep, and fuel utilization in recreationally active adults.

Participants needed: 60
Trial details
Age: 18-50Biological sex: AllType: InterventionalSponsor: Lindenwood UniversityUpdated: Dec 12, 2025Locations: 1
Eligibility criteria

Participants who are between 18 - 50 years of age [+7]

Not currently completing at least 180 minutes of moderate to vigorous exercise p... [+19]

Status: Not yet recruiting

Time Restricted Eating in Survivors Trial 2.0

After chemotherapy, older breast cancer survivors experience a faster decline in brain function. This can make it harder to enjoy life, stay social, and maintain independence. Chemotherapy can lead to poorer lifestyle habits, like unhealthy eating, less exercise, high stress, and poor sleep. Chemotherapy can also affect important health markers like blood sugar and cholesterol. Over time, these changes can damage blood vessels, which might lead to heart and brain issues. The investigators do not fully understand why brain function declines faster after chemotherapy, especially in older survivors, because there are many factors involved. In this study, the investigators will look at how lifestyle habits (like diet, exercise, stress and sleep), health markers (like blood sugar and cholesterol), and blood vessel health (like how well blood flows and how stiff the blood vessels are) affect brain function in older breast cancer survivors. The investigators will include 152 females aged 60-85 years, who finished chemotherapy for early-stage breast cancer at least 1 year ago. The investigators will use special tests to check different parts of brain function, like language, memory, and attention, as well as brain blood vessel health. This will help to understand which factors might speed up or slow down memory and thinking problems. Since many Canadian breast cancer survivors experience faster decline in brain function after chemotherapy, this study aims to find out what might make it worse. The results could help to create better and more personalized treatment plans for older breast cancer survivors that protect brain health and reduce problems with brain function in the future.

Participants needed: 152
Trial details
Age: 60-85Biological sex: FemaleType: InterventionalSponsor: University of TorontoUpdated: Dec 2, 2025Locations: 1
Eligibility criteria

female [+5]

does not have a mobile device that connects to Bluetooth and can send/receive te... [+14]

Status: Not yet recruiting

Exploring the Effectiveness of Somatosensory Cognitive Game Intervention on Cognitive and Physical Functions

This study investigates the effects of somatosensory cognitive games interventions on older adults' cognitive and physical functions. The investigators plan to recruit up to 100 participants and randomly assign them to a control group or an experimental group. The experimental group will participate in somatosensory cognitive games for 12 weeks, while the control group will receive routine care. Data will be collected via questionnaires to examine whether somatosensory cognitive games can delay declines in cognitive and physical functions in older adults.

Participants needed: 80
Trial details
Age: 65-100Biological sex: AllType: InterventionalSponsor: Taipei Medical UniversityUpdated: Nov 26, 2025
Eligibility criteria

Elderly individuals aged 65 and above. [+2]

Individuals with severe visual impairments or physical mobility disabilities tha... [+1]

Status: Recruiting

Sarcopenia in Gestational Diabetes

Sarcopenia is a syndrome characterized by loss of skeletal muscle mass and strength, and physical performance deterioration. Prevalence of sarcopenia in elderly people is remarkably high (prevalence of about 25% in 60+ years people). In type 2 diabetes (T2D), sarcopenia is emerging as comorbidity of major concern. Sarcopenia, however, is not limited to elderly people, as it can develop also in younger individuals with prevalence around 9% or even higher according to some investigators. Of note, sarcopenia has been reported even in the 20-29 years interval. This interval includes women of childbearing age, thus raising the question whether sarcopenia may occur also in women with gestational diabetes (GDM) and whether this may affect pregnancy outcomes. Also, association between sarcopenia and cognitive impairment has been repeatedly reported, to the point that some authors have emphasized the importance of early sarcopenia recognition for prevention of cognitive impairment. Therefore, our main aims are: 1. To ascertain whether sarcopenia is present in GDM and, in that case, its prevalence; 2. To identify risk factors for sarcopenia; 3. To determine sarcopenia impact on pregnancy outcomes, and cognitive function. During pregnancy, all women will undergo oral glucose tolerance test (OGTT) for assessment of the glucometabolic condition. Several clinical variables of interest in sarcopenia will also be recorded. As regards the OGTT data, special focus will be on the assessment of insulin resistance, both at fasting and during the dynamic conditions determined by the OGTT. Notably, the special interest for insulin resistance is due to the reason that this type of metabolic alteration is known to be a risk factor for sarcopenia. In fact, all women will then undergo testing for diagnosis of sarcopenia (or presarcopenia), and all data and parameters will be analyzed to identify relationships between sarcopenia-related variables and GDM-related ones. It is worth noting that in consideration of the exacerbated insulin resistance condition often observed in GDM, the investigators expect indeed a not negligible prevalence of sarcopenia (or at least presarcopenia) in GDM women, despite the young (non-elderly) age. In addition, since insulin resistance is often present in pregnancy even in the absence of dysglycemia, the investigators do not exclude to identify some cases of sarcopenia/presarcopenia even in pregnant non-GDM women. This study will be the basis for future studies (also of interventional type), especially in women with GDM for prevention of sarcopenia and related possible pregnancy complication and adverse pregnancy outcomes, as well as for possibly contributing to mitigation of risk for T2D development in later life.

Participants needed: 200
Trial details
Age: 35+Biological sex: FemaleType: ObservationalSponsor: Istituto di Neuroscienze Consiglio Nazionale delle RicercheUpdated: Nov 21, 2025Locations: 3
Eligibility criteria

Age equal to or higher than 35 years; [+5]

Unmatching of at least one among the inclusion criteria; [+4]

Status: Not yet recruiting

The Effects of Visual Input on Cognitive Function, Physical Performance, and Postural Stability in Adolescent Male Basketball Players

The aim of this study is to investigate the effects of exercises performed with stroboscopic glasses-recently gaining popularity in sports-on cognitive function, physical performance, and postural stability, which are among the key skills in athletic performance. The originality of the study lies in being the first to examine the effects of stroboscopic glasses-based exercises on basketball players. Hypotheses of the study: H1: Exercises performed with stroboscopic glasses have an effect on athletes' cognitive functions. H2: Exercises performed with stroboscopic glasses have an effect on athletes' physical performance. H3: Exercises performed with stroboscopic glasses have an effect on athletes' static and dynamic postural stability.

Participants needed: 36
Trial details
Age: 14-19Biological sex: MaleType: InterventionalSponsor: Hacettepe UniversityUpdated: Sep 11, 2025
Eligibility criteria

Male basketball players aged 14-19 years [+2]

Not willing to participate in the study [+5]

Status: Recruiting

Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients

The main goal of this project is to study the mechanisms of epileptic activities using intracranial macro and micro electrodes in epileptic patients undergoing pre-surgical investigation. The recordings will also be used to study physiological mechanisms like sleep and different cognitive functions.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Institut National de la Santé Et de la Recherche Médicale, FranceUpdated: Sep 8, 2025Locations: 1
Eligibility criteria

Patients with focal drug-resistant epilepsy [+2]

Contraindication for an intracranial investigation (with macro-electrodes) : int... [+3]

Status: Not yet recruiting

Square Step Exercises in Healthy Young Adults

This study aims to compare the effectiveness of Square Stepping Exercise and aerobic exercise on cognitive function and physical fitness in young adults. Participants aged 18-30 with low physical activity levels will be randomly assigned to either the Square Stepping Exercise Group or Aerobic Exercise Group. Both interventions will be supervised by a physiotherapist, performed twice a week for 40 minutes over 4 weeks. Cognitive function will be assessed using various tests, including attention, short-term memory, and executive function evaluations. Physical fitness will be evaluated through jump tests and balance assessments. Blinded assessors will conduct evaluations at baseline and post-intervention in both groups to determine the impact of square stepping exercise and aerobic exercise on cognitive and physical health in young adults.

Participants needed: 50
Trial details
Age: 18-30Biological sex: AllType: InterventionalSponsor: Fenerbahce UniversityUpdated: Aug 19, 2025Locations: 1
Eligibility criteria

International Physical Activity Questionnaire score <600 Metabolic Equivalents (... [+2]

Participants who have pain due to a musculoskeletal problem [+1]